Home > Qtrly Results > DIVIS LABORATORIES

DIVIS LABORATORIES
Quarterly Results Analysis [Mar2023]

DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Quarterly Results

Consolidated Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
Audited
Dec2021
Audited
Sep2021
Audited
Jun2021
UnAudited
Revenues ₹1,951 Cr ₹1,708 Cr ₹1,855 Cr ₹2,255 Cr ₹2,518 Cr ₹2,493 Cr ₹1,988 Cr ₹1,961 Cr
Expenses ₹1,463 Cr ₹1,299 Cr ₹1,234 Cr ₹1,408 Cr ₹1,414 Cr ₹1,396 Cr ₹1,169 Cr ₹1,109 Cr
Operating Income ₹488 Cr ₹408 Cr ₹621 Cr ₹847 Cr ₹1,104 Cr ₹1,097 Cr ₹818 Cr ₹852 Cr
Other Income ₹66 Cr ₹114 Cr ₹80 Cr ₹88 Cr ₹52 Cr ₹17 Cr ₹19 Cr ₹36 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹87 Cr ₹87 Cr ₹86 Cr ₹84 Cr ₹81 Cr ₹80 Cr ₹77 Cr ₹73 Cr
Profit Before Tax ₹466 Cr ₹436 Cr ₹615 Cr ₹851 Cr ₹1,076 Cr ₹1,034 Cr ₹760 Cr ₹814 Cr
Profit After Tax ₹321 Cr ₹307 Cr ₹494 Cr ₹702 Cr ₹895 Cr ₹902 Cr ₹606 Cr ₹557 Cr
EPS ₹12.09 ₹11.56 ₹18.59 ₹26.45 ₹33.70 ₹33.99 ₹22.85 ₹20.99
Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES 0.5% 4.8% 0.3%
SUN PHARMACEUTICAL INDUSTRIES 2.7% 5.9% 17.9%
CIPLA -0.4% 2.3% -1.5%
DR REDDYS LABORATORIES 2.6% -5.3% 7%
TORRENT PHARMACEUTICALS 1.5% 9.3% 27.1%
ABBOTT INDIA 1.3% -0.2% 18.8%
ZYDUS LIFESCIENCES 0.3% -1.9% 41.3%
ALKEM LABORATORIES 0.8% -5.8% 9.5%
LUPIN 0.8% 9.7% 34%

DIVIS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

14.24 %

Y-o-Y

-22.54 %

Quarters Revenues % Change
Mar2023 ₹1,951 Cr
14.24
Dec2022 ₹1,708 Cr
-7.92
Sep2022 ₹1,855 Cr
-17.74
Jun2022 ₹2,255 Cr
-10.48
Mar2022 ₹2,518 Cr
1.01
Dec2021 ₹2,493 Cr
25.45
Sep2021 ₹1,988 Cr
1.37
Jun2021 ₹1,961 Cr -

DIVIS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

19.43 %

Y-o-Y

-55.85 %

Quarters Operating Profit % Change
Mar2023 ₹488 Cr
19.43
Dec2022 ₹408 Cr
-34.26
Sep2022 ₹621 Cr
-26.65
Jun2022 ₹847 Cr
-23.34
Mar2022 ₹1,104 Cr
0.66
Dec2021 ₹1,097 Cr
34.12
Sep2021 ₹818 Cr
-3.99
Jun2021 ₹852 Cr -
Operating Margins
Q-o-Q

4.52 %

Y-o-Y

-43.01 %

Quarters Operating Margin% % Change
Mar2023 24.99%
4.52
Dec2022 23.91%
-28.61
Sep2022 33.49%
-10.84
Jun2022 37.56%
-14.34
Mar2022 43.85%
-0.36
Dec2021 44.01%
6.92
Sep2021 41.16%
-5.29
Jun2021 43.46% -

DIVIS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

4.62 %

Y-o-Y

-64.12 %

Quarters Profit After Tax % Change
Mar2023 ₹321 Cr
4.62
Dec2022 ₹307 Cr
-37.84
Sep2022 ₹494 Cr
-29.69
Jun2022 ₹702 Cr
-21.53
Mar2022 ₹895 Cr
-0.84
Dec2021 ₹902 Cr
48.77
Sep2021 ₹606 Cr
8.86
Jun2021 ₹557 Cr -
PAT Margins
Q-o-Q

-8.46 %

Y-o-Y

-53.69 %

Quarters PAT Margin(%) % Change
Mar2023 16.45 %
-8.46
Dec2022 17.97 %
-32.49
Sep2022 26.62 %
-14.52
Jun2022 31.14 %
-12.33
Mar2022 35.52 %
-1.85
Dec2021 36.19 %
18.62
Sep2021 30.51 %
7.39
Jun2021 28.41 % -

DIVIS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

4.58 %

Y-o-Y

-64.12 %

Quarters EPS % Change
Mar2023 ₹12.09
4.58
Dec2022 ₹11.56
-37.82
Sep2022 ₹18.59
-29.72
Jun2022 ₹26.45
-21.51
Mar2022 ₹33.7
-0.85
Dec2021 ₹33.99
48.75
Sep2021 ₹22.85
8.86
Jun2021 ₹20.99 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].